Pharmaceutical

Class 05: Pharmaceutical Trademarks?

Filing Activity Analysis: Supplements on the rise The 11th (2020) Edition of the Nice Classification describes Class 5 as “mainly pharmaceuticals and other preparations for medical or veterinary purposes”. When most people hear the word “pharmaceuticals” in the context of trademarks, they think of traditional areas of medicine such as cancer, vaccines, antibiotics, diabetes and […]

Use as directed: Navigating the complexities of pharmaceutical trademarks

The global market for pharmaceutical products reached $1.2 trillion in 2018 – up $100 billion from the prior year. This is projected to reach $1.5 trillion by 2021. New developments in biotechnology, nanotechnology and digital medicine are rapidly transforming the definition of pharma products. These trends are creating an ever-more crowded and complex brand landscape. […]

Overcoming key challenges in drug naming

The global market for pharmaceutical products reached $1.2 trillion in 2018 – up $100 billion from the prior year. It is projected to reach $1.5 trillion by 2023.[1] By another measure, this translates into more than 40,000 Class 5 trademark applications submitted to Trademark Offices around the world in 2018, on top of 300,000+ already […]